These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 25453423)
1. The use of paralytics in patients with acute respiratory distress syndrome. Hraiech S; Dizier S; Papazian L Clin Chest Med; 2014 Dec; 35(4):753-63. PubMed ID: 25453423 [TBL] [Abstract][Full Text] [Related]
2. Paralytics in critical care: not always the bad guy. Forel JM; Roch A; Papazian L Curr Opin Crit Care; 2009 Feb; 15(1):59-66. PubMed ID: 19186410 [TBL] [Abstract][Full Text] [Related]
3. To Block or Not: Updates in Neuromuscular Blockade in Acute Respiratory Distress Syndrome. Mefford B; Donaldson JC; Bissell BD Ann Pharmacother; 2020 Sep; 54(9):899-906. PubMed ID: 32111121 [No Abstract] [Full Text] [Related]
4. Neuromuscular blockers in the acute respiratory distress syndrome: A meta-analysis. Hua Y; Ou X; Li Q; Zhu T PLoS One; 2020; 15(1):e0227664. PubMed ID: 31961896 [TBL] [Abstract][Full Text] [Related]
5. The role of neuromuscular blockers in ARDS: benefits and risks. Hraiech S; Forel JM; Papazian L Curr Opin Crit Care; 2012 Oct; 18(5):495-502. PubMed ID: 22941207 [TBL] [Abstract][Full Text] [Related]
6. Sedation and neuromuscular blocking agents in acute respiratory distress syndrome. Bourenne J; Hraiech S; Roch A; Gainnier M; Papazian L; Forel JM Ann Transl Med; 2017 Jul; 5(14):291. PubMed ID: 28828366 [TBL] [Abstract][Full Text] [Related]
14. Heterotopic ossification due to neuromuscular blocking agent in adult respiratory distress syndrome. A case report. Zynnurodlu M; Kaymak Karatap G; Sepycy V Eur J Phys Rehabil Med; 2008 Mar; 44(1):81-5. PubMed ID: 18385631 [TBL] [Abstract][Full Text] [Related]
15. Neuromuscular blocking agents for adult patients with acute respiratory distress syndrome: A meta-analysis of randomized controlled trials. Tao W; Yang LQ; Gao J; Shao J J Trauma Acute Care Surg; 2018 Dec; 85(6):1102-1109. PubMed ID: 30462621 [TBL] [Abstract][Full Text] [Related]
16. Myorelaxants in ARDS patients. Hraiech S; Yoshida T; Annane D; Duggal A; Fanelli V; Gacouin A; Heunks L; Jaber S; Sottile PD; Papazian L Intensive Care Med; 2020 Dec; 46(12):2357-2372. PubMed ID: 33159530 [TBL] [Abstract][Full Text] [Related]
17. Neuromuscular Blockade in the 21st Century Management of the Critically Ill Patient. deBacker J; Hart N; Fan E Chest; 2017 Mar; 151(3):697-706. PubMed ID: 27818334 [TBL] [Abstract][Full Text] [Related]
18. A Markov computer simulation model of the economics of neuromuscular blockade in patients with acute respiratory distress syndrome. Macario A; Chow JL; Dexter F BMC Med Inform Decis Mak; 2006 Mar; 6():15. PubMed ID: 16539706 [TBL] [Abstract][Full Text] [Related]
19. Current therapeutic uses, pharmacology, and clinical considerations of neuromuscular blocking agents for critically ill adults. Warr J; Thiboutot Z; Rose L; Mehta S; Burry LD Ann Pharmacother; 2011 Sep; 45(9):1116-26. PubMed ID: 21828347 [TBL] [Abstract][Full Text] [Related]
20. [Clinical study of early use of neuromuscular blocking agents in patients with severe sepsis and acute respiratory distress syndrome]. Lyu G; Wang X; Jiang W; Cai T; Zhang Y Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 May; 26(5):325-9. PubMed ID: 24809261 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]